Planning

HLA Sequencing Systems

NHS BLOOD AND TRANSPLANT

This public procurement record has 1 release in its history.

Planning

06 May 2021 at 13:19

Planning Notice
Summary of the contracting process

The NHS Blood and Transplant (NHSBT) is initiating a planned tender for the procurement of HLA sequencing systems, centred in the health industry category of medical equipment. Located in Bristol, UK, this procurement is currently at the Planning stage. Interested suppliers are invited to express their interest by 17:00 GMT on 28th May 2021, in order to participate in pre-procurement engagement meetings scheduled for the week of 7th to 11th June 2021. The current contract for the required systems concludes in July 2022, establishing the urgency for market engagement to enhance NHSBT’s understanding of available technologies.

This tender represents a significant opportunity for businesses specialising in medical technology, particularly those offering diagnostic kits, medical consumables, and repair services for medical equipment. Suppliers that can provide innovative HLA typing systems and related products will be particularly well-positioned to compete. It is worth noting that participation in this tender process does not guarantee any business, emphasizing the need for an understanding of this competitive landscape by potential bidders.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

HLA Sequencing Systems

Notice Description

Please see section II.2.4 for details. Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA sequencing systems. Our current contract ends in June 2022 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field.

Lot Information

Lot 1

NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake an OJEU tender exercise for the supply of HLA sequencing systems.Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, providing testing and support in transplantation, specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology. Services are supplied through a national network of six laboratories across England. Building on our strengths as a national provider, NHSBT's strategic aim is for its diagnostic services to become the preferred provider and supplier of choice for these services in the NHS in England. We would like to work with future suppliers to realise this ambition and to perform HLA typing in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve.Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA sequencing systems. Our current contract ends in July 2022 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field. We require HLA typing systems to cover the following:* Allelic Test Kits SHOULD detect and uniquely identify all alleles of the HLA-A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1 and DPB1 loci at the level of resolution that additionally defines the third field according to WHO nomenclature by at least resolving all ambiguities resulting from: (1) polymorphisms located within the exons coding for HLA class I and class II proteins and (2) that encompass a null allele wherever the polymorphism is located.* The optimal solution SHOULD define fourth field level resolution* Provision of maintenance, reagents and consumables for our existing instruments (Miseq (Illumina) pre-April 2021).NB: Procurement of the above systems may be managed by individual tenders.It is NHSBT's intention to hold pre-procurement engagement meetings the week of 7th to 11th June 2021, these will be held remotely, the date to be confirmed. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to marta.drozdzowska@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 28/05/21. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract.No business whatsoever is guaranteed under any resulting framework agreement or contract, indeed there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position.It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02aded
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/009852-2021
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

50 - Repair and maintenance services

CPV Codes

33100000 - Medical equipments

33140000 - Medical consumables

33141625 - Diagnostic kits

50421000 - Repair and maintenance services of medical equipment

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
6 May 20214 years ago
Submission Deadline
Not specified
Future Notice Date
30 Sep 2021Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Marta Drozdzowska
Contact Email
marta.drozdzowska@nhsbt.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
BRISTOL
Postcode
BS16 7FG
Post Town
Bristol
Country
England
Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified
Local Authority
South Gloucestershire
Electoral Ward
Emersons Green
Westminster Constituency
Filton and Bradley Stoke

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02aded-2021-05-06T14:19:33+01:00",
    "date": "2021-05-06T14:19:33+01:00",
    "ocid": "ocds-h6vhtk-02aded",
    "initiationType": "tender",
    "tender": {
        "id": "C29972",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "HLA Sequencing Systems",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "33100000",
            "description": "Medical equipments"
        },
        "mainProcurementCategory": "goods",
        "description": "Please see section II.2.4 for details. Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA sequencing systems. Our current contract ends in June 2022 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field.",
        "lots": [
            {
                "id": "1",
                "description": "NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake an OJEU tender exercise for the supply of HLA sequencing systems.Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, providing testing and support in transplantation, specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology. Services are supplied through a national network of six laboratories across England. Building on our strengths as a national provider, NHSBT's strategic aim is for its diagnostic services to become the preferred provider and supplier of choice for these services in the NHS in England. We would like to work with future suppliers to realise this ambition and to perform HLA typing in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve.Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA sequencing systems. Our current contract ends in July 2022 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field. We require HLA typing systems to cover the following:* Allelic Test Kits SHOULD detect and uniquely identify all alleles of the HLA-A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1 and DPB1 loci at the level of resolution that additionally defines the third field according to WHO nomenclature by at least resolving all ambiguities resulting from: (1) polymorphisms located within the exons coding for HLA class I and class II proteins and (2) that encompass a null allele wherever the polymorphism is located.* The optimal solution SHOULD define fourth field level resolution* Provision of maintenance, reagents and consumables for our existing instruments (Miseq (Illumina) pre-April 2021).NB: Procurement of the above systems may be managed by individual tenders.It is NHSBT's intention to hold pre-procurement engagement meetings the week of 7th to 11th June 2021, these will be held remotely, the date to be confirmed. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to marta.drozdzowska@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 28/05/21. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract.No business whatsoever is guaranteed under any resulting framework agreement or contract, indeed there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position.It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33141625",
                        "description": "Diagnostic kits"
                    },
                    {
                        "scheme": "CPV",
                        "id": "50421000",
                        "description": "Repair and maintenance services of medical equipment"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2021-10-01T00:00:00+01:00",
            "atypicalToolUrl": "http://health.atamis.co.uk"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-15374",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "legalName": "NHS Blood and Transplant",
                "id": "123"
            },
            "address": {
                "streetAddress": "203 Longmead Rd, Avon",
                "locality": "Bristol",
                "region": "UKK12",
                "postalCode": "BS16 7FG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Marta Drozdzowska",
                "email": "marta.drozdzowska@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.test.com",
                "buyerProfile": "https://www.test.com",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-15374",
        "name": "NHS Blood and Transplant"
    },
    "language": "en"
}